Quantification of LEC number in tumor-bearing mammary fat pads by flow cytometry (Fig. 5d) revealed expansion of the LEC population (gp38+/CD31+/CD45-) [22] with docetaxel treatment, which was significantly mitigated by VEGFR3 blocking. This evidence concerns the gene PDPN and neoplasm.